Allspring Global Investments
DCPH

Allspring Global Investments’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Allspring Global Investments’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20,990
Closed -$330K – 2557
2024
Q1 		$330K Sell
20,990
-392
-2% -$6.03K ﹤0.01% 1615
2023
Q4 		$345K Sell
21,382
-52,171
-71% -$665K ﹤0.01% 1582
2023
Q3 		$936K Sell
73,553
-64,878
-47% -$895K ﹤0.01% 1377
2023
Q2 		$1.95M Sell
138,431
-9,028
-6% -$129K ﹤0.01% 1244
2023
Q1 		$2.28M Buy
147,459
+55,684
+61% +$930K ﹤0.01% 1209
2022
Q4 		$1.5M Buy
91,775
+63,927
+230% +$1.04M ﹤0.01% 1320
2022
Q3 		$515K Buy
27,848
+3,888
+16% +$61K ﹤0.01% 1577
2022
Q2 		$315K Sell
23,960
-11,000
-31% -$121K ﹤0.01% 1689
2022
Q1 		$324K Buy
34,960
+19,457
+126% +$165K ﹤0.01% 2411
2021
Q4 		$151K Buy
+15,503
New +$292K ﹤0.01% 2695

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Allspring Global Investments's DCPH Position: Q2 2024 in Review

Allspring Global Investments sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 20,990 shares — an estimated $330K sold.

Allspring Global Investments first reported a position in DCPH in Q4 2021 and held it in 10 quarters. The position peaked at $2.28M in Q1 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Allspring Global Investments reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Allspring Global Investments sold 20,990 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $330K.
  • Allspring Global Investments first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
  • Allspring Global Investments's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2.28M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Allspring Global Investments's 13F filing for Q2 2024, filed 26 Jul 2024.